Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Kissei Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	192,755	164,586	156,266	121,792	117,826	112,984
Market Cap Growth	28.29%	5.32%	28.31%	3.36%	4.29%	-13.03%
Enterprise Value	133,572	122,521	115,492	77,037	78,311	68,996
Last Close Price	4650.00	3793.10	3395.74	2477.94	2323.47	2179.00
PE Ratio	13.59	13.76	14.00	11.57	9.12	21.38
Forward PE	16.21	17.88	14.26	10.90	36.67	28.42
PS Ratio	2.10	1.86	2.07	1.81	1.80	1.64
PB Ratio	0.91	0.78	0.71	0.63	0.58	0.51
P/TBV Ratio	0.92	0.80	0.72	0.63	0.59	0.52
P/FCF Ratio	30.49	81.72	-	-	2677.87	-
P/OCF Ratio	16.43	25.24	-	-	76.86	-
EV/Sales Ratio	1.46	1.39	1.53	1.14	1.20	1.00
EV/EBITDA Ratio	76.68	11.79	13.96	25.97	33.64	14.83
EV/EBIT Ratio	-	21.22	28.75	-	-	45.81
EV/FCF Ratio	21.13	60.83	-	-	1779.80	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.73	0.12	0.16	0.50	0.70	0.37
Debt / FCF Ratio	0.20	0.64	-	-	37.27	-
Asset Turnover	0.35	0.35	0.31	0.29	0.26	0.28
Inventory Turnover	1.76	1.73	1.56	1.68	1.75	2.17
Quick Ratio	2.68	4.68	4.17	4.79	4.01	3.70
Current Ratio	3.57	6.45	5.92	6.73	5.30	5.10
Return on Equity (ROE)	6.74%	5.55%	5.43%	5.36%	6.17%	2.60%
Return on Assets (ROA)	-0.68%	1.43%	1.04%	-0.31%	-0.35%	0.38%
Return on Invested Capital (ROIC)	-1.49%	2.61%	1.94%	-0.60%	-0.68%	0.69%
Return on Capital Employed (ROCE)	-1.30%	2.50%	1.70%	-0.60%	-0.60%	0.60%
Earnings Yield	7.52%	7.27%	7.14%	8.64%	10.97%	4.68%
FCF Yield	3.28%	1.22%	-1.84%	-7.21%	0.04%	-3.07%
Dividend Yield	2.56%	2.64%	2.42%	3.23%	2.41%	2.48%
Payout Ratio	35.06%	31.78%	33.35%	29.78%	19.63%	46.83%
Buyback Yield / Dilution	4.61%	3.62%	1.86%	-	1.18%	0.11%
Total Shareholder Return	7.17%	6.25%	4.27%	3.23%	3.59%	2.58%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.